AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24436240 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia (35°C)
Number of subjects: 36
Study 24436240 — intervention group
Group type: COMPARATOR
Intervention: Standard stroke unit care (Control)
Number of subjects: 36
Study 22617844 — intervention group
Group type: EXPERIMENTAL
Intervention: HibMenCY-TT coadministered with MMR and VAR
Number of subjects: 1257
Study 22617844 — intervention group
Group type: COMPARATOR
Intervention: Hib conjugate vaccine coadministered with MMR and VAR
Number of subjects: 1257
Study 21050401 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid angioplasty and stenting
Number of subjects: 0
Study 21050401 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 0
Study 21050401 — intervention group
Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 0
Study 17560680 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenalin (0.1-0.7 microg/kg/min) and albumin
Number of subjects: 22
Study 17560680 — intervention group
Group type: COMPARATOR
Intervention: Terlipressin (1-2 mg/4h) and albumin
Number of subjects: 22
Study 15561446 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance use reduction (SR)
Number of subjects: 133
Study 15561446 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity increase (AI)
Number of subjects: 133
Study 15561446 — intervention group
Group type: COMPARATOR
Intervention: No-change control
Number of subjects: 133
Study 14658376 — intervention group
Group type: EXPERIMENTAL
Intervention: 305C (females)
Number of subjects: 45
Study 14658376 — intervention group
Group type: COMPARATOR
Intervention: 305B (males)
Number of subjects: 45
Study 14658376 — intervention group
Group type: COMPARATOR
Intervention: Comparison of reverse dives
Number of subjects: 45
Study 9474615 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg of oral acyclovir twice daily (1600 mg/day) for 3 to 7 days before sun exposure
Number of subjects: 239
Study 9474615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study 8351436 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenestrated sheath
Number of subjects: 153
Study 8351436 — intervention group
Group type: COMPARATOR
Intervention: Ordinary nonfenestrated sheath
Number of subjects: 153
Study 3565338 — intervention group
Group type: COMPARATOR
Intervention: Psyllium (7.2 g/day)
Number of subjects: 42
Study 3565338 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium plus senna (6.5 + 1.5 g/day)
Number of subjects: 42
Study 3565338 — intervention group
Group type: EXPERIMENTAL
Intervention: Both laxatives
Number of subjects: 42
Study 30477852 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-minute facial massage roller on the right cheek
Number of subjects: 26
Study 30477852 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-week daily use of facial massage roller on the right cheek
Number of subjects: 26
Study 27696929 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation sessions (2 sessions per week for 1 month, total of 8 sessions)
Number of subjects: 0
Study 27696929 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 24700490 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafenoquine 1200 mg
Number of subjects: 52
Study 24700490 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafenoquine 300 mg
Number of subjects: 52
Study 24700490 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafenoquine 600 mg
Number of subjects: 52
Study 24700490 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 52
Study 24700490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 22435835 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-run, telephone-based outreach intervention
Number of subjects: 762
Study 22435835 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 762
Study 20609641 — intervention group
Group type: EXPERIMENTAL
Intervention: Minnesota Code (MC)
Number of subjects: 64597
Study 20609641 — intervention group
Group type: EXPERIMENTAL
Intervention: Novacode (NC)
Number of subjects: 64597
Study 20609641 — intervention group
Group type: EXPERIMENTAL
Intervention: Major ST-T abnormalities (MC or NC)
Number of subjects: 64597
Study 17884359 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive statin therapy (high-dose)
Number of subjects: 8658
Study 17884359 — intervention group
Group type: COMPARATOR
Intervention: Moderate statin therapy (standard-dose)
Number of subjects: 8658
Study 16130584 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel cancer and physical activity message (n = 141)
Number of subjects: 281
Study 16130584 — intervention group
Group type: COMPARATOR
Intervention: Heart disease and physical activity message (n = 140)
Number of subjects: 281
Study 11877613 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrillated cartilage (group B)
Number of subjects: 73
Study 11877613 — intervention group
Group type: COMPARATOR
Intervention: Eburnated bone (group A)
Number of subjects: 73
Study 10440463 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 1 mg
Number of subjects: 0
Study 8950071 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg, given orally)
Number of subjects: 20
Study 8950071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1742248 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg (Indocid)
Number of subjects: 16
Study 1742248 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaprofenic acid 100 mg (Surgam)
Number of subjects: 16
Study 1742248 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium acetylsalicylate 1 g (Catalgine)
Number of subjects: 16
Study 1742248 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 16
Study 7081727 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine sulfate 10 mg
Number of subjects: 10
Study 7081727 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar epidural morphine 10 mg
Number of subjects: 10
Study 31531525 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban combined with Solitaire AB stent
Number of subjects: 120
Study 31531525 — intervention group
Group type: COMPARATOR
Intervention: Thrombectomy with cerebral artery stents alone
Number of subjects: 120
Study 28316174 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine (starting dose 5 mg bid, uptitrated to 7.5 mg bid)
Number of subjects: 225
Study 28316174 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 225
Study 28316174 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 225
Study 25888726 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR) training
Number of subjects: 232
Study 25888726 — intervention group
Group type: COMPARATOR
Intervention: Non-participants
Number of subjects: 232
Study 24379072 — intervention group
Group type: EXPERIMENTAL
Intervention: Group T (TIVA with propofol)
Number of subjects: 40
Study 24379072 — intervention group
Group type: COMPARATOR
Intervention: Group C (Inhalation anesthesia with desflurane)
Number of subjects: 40
Study 20598710 — intervention group
Group type: EXPERIMENTAL
Intervention: rEEG-guided pharmacotherapy
Number of subjects: 114
Study 20598710 — intervention group
Group type: COMPARATOR
Intervention: Control (venlafaxine XR or STAR*D regimen)
Number of subjects: 114
Study 19972661 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Wordsworth DVD
Number of subjects: 100
Study 19972661 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DVD)
Number of subjects: 100
Study 17511752 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily estimation assessment procedures
Number of subjects: 0
Study 17511752 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment batteries
Number of subjects: 0
Study 14747225 — intervention group
Group type: EXPERIMENTAL
Intervention: Caiapo (4 g once daily for 12 weeks)
Number of subjects: 61
Study 14747225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 11427767 — intervention group
Group type: EXPERIMENTAL
Intervention: Total volume of physical activity (measured in MET-min x wk(-1))
Number of subjects: 34
Study 11427767 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity of physical activity
Number of subjects: 34
Study 11427767 — intervention group
Group type: EXPERIMENTAL
Intervention: Total volume of physical activity
Number of subjects: 34
Study 9596235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) loading infusion of 16 mmol followed by 65 mmol over 24 hours
Number of subjects: 25
Study 9596235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) loading infusion of 12 mmol followed by 65 mmol over 24 hours
Number of subjects: 25
Study 9596235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) loading infusion of 8 mmol followed by 65 mmol over 24 hours
Number of subjects: 25
Study 9596235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 8883720 — intervention group
Group type: EXPERIMENTAL
Intervention: HI group (high electrosurgical current intensity)
Number of subjects: 38
Study 8883720 — intervention group
Group type: COMPARATOR
Intervention: LO group (low electrosurgical current intensity)
Number of subjects: 38
Study 2649156 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 86
Study 2649156 — intervention group
Group type: EXPERIMENTAL
Intervention: State-Adjusted Treatment (SAT)
Number of subjects: 86
Study 2649156 — intervention group
Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 86
Study 2649156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 2649156 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (in manic inpatients)
Number of subjects: 86
Study 2649156 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptics (in manic inpatients)
Number of subjects: 86
Study 327853 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (Ho‐Ku)
Number of subjects: 40
Study 327853 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine
Number of subjects: 40
Study 327853 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine plus Acupuncture (Ho‐Ku)
Number of subjects: 40
Study 327853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31013550 — intervention group
Group type: EXPERIMENTAL
Intervention: Δ9-tetrahydrocannabinol (THC) (8 mg)
Number of subjects: 48
Study 31013550 — intervention group
Group type: EXPERIMENTAL
Intervention: THC + cannabidiol (THC + CBD) (8 + 16 mg)
Number of subjects: 48
Study 31013550 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (8 mg)
Number of subjects: 48
Study 31013550 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD (16 mg)
Number of subjects: 48
Study 31013550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 30447912 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC) intervention
Number of subjects: 106
Study 30447912 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 106
Study 30447912 — intervention group
Group type: COMPARATOR
Intervention: Low-risk comparison group
Number of subjects: 106
Study 26450601 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Mediterranean diet supplemented with extra virgin olive oil (EVOO)
Number of subjects: 90
Study 26450601 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Mediterranean diet supplemented with nuts
Number of subjects: 90
Study 26450601 — intervention group
Group type: COMPARATOR
Intervention: Control low-fat diet
Number of subjects: 90
Study 25872925 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination at birth
Number of subjects: 560
Study 25872925 — intervention group
Group type: COMPARATOR
Intervention: BCG vaccination at 6 weeks of age
Number of subjects: 560
Study 23407746 — intervention group
Group type: EXPERIMENTAL
Intervention: Social validation for killing bugs (manipulated through confederate actions)
Number of subjects: 0
Study 23407746 — intervention group
Group type: COMPARATOR
Intervention: Social invalidation for killing bugs (manipulated through confederate actions)
Number of subjects: 0
Study 21294997 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg loxapine
Number of subjects: 129
Study 21294997 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg loxapine
Number of subjects: 129
Study 21294997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 19348600 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide 2% added to timolol 0.5%
Number of subjects: 146
Study 19348600 — intervention group
Group type: COMPARATOR
Intervention: Brinzolamide 1% added to timolol 0.5%
Number of subjects: 146
Study 18246742 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone treatment
Number of subjects: 114
Study 15264734 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuohy needle (Group N, n=31)
Number of subjects: 79
Study 15264734 — intervention group
Group type: COMPARATOR
Intervention: Epidural catheter (Group C, n=28)
Number of subjects: 79
Study 15264734 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuohy needle (Group NE, n=10)
Number of subjects: 79
Study 15264734 — intervention group
Group type: COMPARATOR
Intervention: Epidural catheter (Group CE, n=10)
Number of subjects: 79
Study 11565669 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-g albumin
Number of subjects: 60
Study 11565669 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-g albumin
Number of subjects: 60
Study 11565669 — intervention group
Group type: COMPARATOR
Intervention: No albumin
Number of subjects: 60
Study 9610448 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffractive bifocal IOL
Number of subjects: 221
Study 9610448 — intervention group
Group type: COMPARATOR
Intervention: Monofocal IOL
Number of subjects: 221
Study 9610448 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral diffractive bifocal IOL
Number of subjects: 221
Study 7922833 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine sulphate 0.04 mg/kg followed by propranolol 0.2 mg/kg
Number of subjects: 37
Study 3074299 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 50 mg twice daily (Group A)
Number of subjects: 30
Study 3074299 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 50 mg once daily (Group B)
Number of subjects: 30
Study 29233669 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice-based note creation system
Number of subjects: 709
Study 28350796 — intervention group
Group type: EXPERIMENTAL
Intervention: iCST (75, 30‐min sessions)
Number of subjects: 356
Study 28350796 — intervention group
Group type: EXPERIMENTAL
Intervention: iCST
Number of subjects: 356
Study 28350796 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 356
Study 26725385 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral and sciatic nerve block (SF) group
Number of subjects: 60
Study 26725385 — intervention group
Group type: COMPARATOR
Intervention: Femoral nerve block (F) group
Number of subjects: 60
Study 24461613 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol (150 μg)
Number of subjects: 3444
Study 24461613 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium (18 μg)
Number of subjects: 3444
Study 21722501 — intervention group
Group type: EXPERIMENTAL
Intervention: F60027 (Structovial)
Number of subjects: 276
Study 21722501 — intervention group
Group type: COMPARATOR
Intervention: Hylan G-F20 (Synvisc)
Number of subjects: 276
Study 19451093 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg b.i.d. for 4 weeks
Number of subjects: 0
Study 19451093 — intervention group
Group type: COMPARATOR
Intervention: No drug (control)
Number of subjects: 0
Study 16939509 — intervention group
Group type: EXPERIMENTAL
Intervention: High-velocity varied-resistance training (HV)
Number of subjects: 100
Study 16939509 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow to moderate-velocity constant-resistance training (CT)
Number of subjects: 100
Study 16939509 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined once weekly high-velocity varied-resistance and once weekly gymnasium-based functional training (CB)
Number of subjects: 100
Study 16939509 — intervention group
Group type: COMPARATOR
Intervention: No training (Control - CO)
Number of subjects: 100
Study 16335645 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg PGE2 vaginal tablets (n = 75)
Number of subjects: 147
Study 16335645 — intervention group
Group type: COMPARATOR
Intervention: 50 mL intracervical Foley catheter (n = 72)
Number of subjects: 147
Study 11046104 — intervention group
Group type: EXPERIMENTAL
Intervention: xemilofiban (10 or 20 mg three times daily)
Number of subjects: 7232
Study 11046104 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7232
Study 11046104 — intervention group
Group type: EXPERIMENTAL
Intervention: xemilofiban
Number of subjects: 7232
Study 9505816 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin at a concentration of 5 IU/ml added to infusion fluid (n = 55)
Number of subjects: 111
Study 9505816 — intervention group
Group type: COMPARATOR
Intervention: No heparin (control group, n = 56)
Number of subjects: 111
Study 1447436 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared tympanic membrane (TM) thermometry
Number of subjects: 82
Study 1447436 — intervention group
Group type: COMPARATOR
Intervention: Standard electronic oral (PO) thermometry
Number of subjects: 82
Study 1447436 — intervention group
Group type: COMPARATOR
Intervention: Rectal (R) thermometry
Number of subjects: 82
Study 3903906 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivampicillin, 700 mg twice daily for seven days
Number of subjects: 289
Study 3903906 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole, 500 mg twice daily for seven days
Number of subjects: 289
Study 31329901 — intervention group
Group type: EXPERIMENTAL
Intervention: CT SAT density measurement
Number of subjects: 54
Study 30104371 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent social influence
Number of subjects: 3
Study 30104371 — intervention group
Group type: COMPARATOR
Intervention: Constant social influence
Number of subjects: 3
Study 30104371 — intervention group
Group type: COMPARATOR
Intervention: No social influence
Number of subjects: 3
Study 29336426 — intervention group
Group type: COMPARATOR
Intervention: Weekly oral methotrexate only (Group I)
Number of subjects: 54
Study 29336426 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly oral methotrexate plus soak PUVAsol therapy twice weekly for three months (Group II)
Number of subjects: 54
Study 24604886 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat-enriched diet (OAT)
Number of subjects: 22
Study 24604886 — intervention group
Group type: COMPARATOR
Intervention: Standard dietary advice (SDA)
Number of subjects: 22
Study 24604886 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy test meal (postprandial response)
Number of subjects: 22
Study 22377251 — intervention group
Group type: EXPERIMENTAL
Intervention: CT colonography (CTC)
Number of subjects: 490
Study 20629598 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg LD/10 mg MD)
Number of subjects: 715
Study 20629598 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (30 mg LD/7.5 mg MD)
Number of subjects: 715
Study 20629598 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (30 mg LD/5 mg MD)
Number of subjects: 715
Study 20629598 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (300 mg LD/75 mg MD)
Number of subjects: 715
Study 20629598 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (all dosing regimens)
Number of subjects: 715
Study 17959953 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral melatonin 5 mg
Number of subjects: 33
Study 17959953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 15865226 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine therapy for 1 year (group 1a, n=19)
Number of subjects: 55
Study 15865226 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls (group 1b, n=18)
Number of subjects: 55
Study 15865226 — intervention group
Group type: COMPARATOR
Intervention: Inactive carriers (group 2, n=18)
Number of subjects: 55
Study 15865226 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine treatment (group 1a)
Number of subjects: 55
Study 15865226 — intervention group
Group type: COMPARATOR
Intervention: Observation of untreated patients (group 1b and group 2)
Number of subjects: 55
Study 12464959 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut protein (various doses)
Number of subjects: 26
Study 9651635 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompted physician's advice and individual relapse prevention counseling during pregnancy
Number of subjects: 0
Study 9651635 — intervention group
Group type: COMPARATOR
Intervention: Usual physician advice
Number of subjects: 0
Study 7644961 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 209
Study 7644961 — intervention group
Group type: COMPARATOR
Intervention: Manipulation mimic
Number of subjects: 209
Study 7644961 — intervention group
Group type: COMPARATOR
Intervention: Back education program
Number of subjects: 209
Study 2635231 — intervention group
Group type: EXPERIMENTAL
Intervention: Short rating time group
Number of subjects: 49
Study 2635231 — intervention group
Group type: COMPARATOR
Intervention: Long rating time group
Number of subjects: 49
Study 364210 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflucortolone valerate
Number of subjects: 51
Study 364210 — intervention group
Group type: COMPARATOR
Intervention: Flumetasone pivalate
Number of subjects: 51
Study 31535394 — intervention group
Group type: EXPERIMENTAL
Intervention: Early trophic enteral nutrition (EN); median 384 kcal received while on vasopressors.
Number of subjects: 31
Study 31535394 — intervention group
Group type: COMPARATOR
Intervention: No enteral nutrition (no EN); median 0 kcal received while on vasopressors.
Number of subjects: 31
Study 31103412 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib (200 mg twice daily)
Number of subjects: 458
Study 31103412 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 458
Study 31103412 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 458